Loading...
XSHE
000597
Market cap936mUSD
Jul 10, Last price  
4.51CNY
1D
1.35%
1Q
-16.01%
Jan 2017
0.13%
Name

Northeast Pharmaceutical Group Co

Chart & Performance

D1W1MN
XSHE:000597 chart
P/E
24.75
P/S
0.91
EPS
0.18
Div Yield, %
2.25%
Shrs. gr., 5y
3.09%
Rev. gr., 5y
-0.95%
Revenues
7.04b
-6.15%
2,093,945,3913,706,074,4854,609,773,1785,093,588,3024,828,745,9963,882,779,5913,864,913,0993,870,591,2264,333,321,6423,834,432,0304,814,401,6595,676,351,5537,466,555,2378,220,102,8977,384,354,3748,145,117,4568,808,942,6288,243,175,0207,502,554,9087,041,104,030
Net income
260m
-36.54%
24,583,83247,521,489357,906,459476,079,38153,444,014-394,282,3518,103,659-166,962,66387,075,016-384,357,78723,788,064118,995,327195,199,723173,978,09512,256,83099,027,116350,252,862358,458,438409,848,501260,070,456
CFO
1.11b
+45.81%
0198,560,972709,025,038615,905,583255,962,765086,090,004046,990,98399,700,460384,514,5530285,090,647352,599,584570,918,423746,506,4831,108,571,233586,751,744758,761,1211,106,382,481
Dividend
Jun 23, 20250.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Northeast Pharmaceutical Group Co., Ltd., established in 1993 and headquartered in Shenyang, China, is a key manufacturer and supplier of active pharmaceutical ingredients (APIs) derived from both chemical synthesis and bio-fermentation. The company also develops and distributes various medicinal and micro-ecological preparation products within China. Its broad portfolio includes nutritional supplements such as Vitamin C and L-Carnitine, as well as specific APIs like fosfomycin and anti-AIDS compounds. Furthermore, it produces chemical goods, including pharmaceutical intermediates and chiral separation reagents. Beyond these, Northeast Pharmaceutical manufactures finished drugs for diverse applications, including digestives, narcotic medicines, and treatments for cardiovascular and cerebrovascular conditions. The group also maintains a significant presence in the medical distribution sector.
IPO date
May 23, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT